The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia, 2018
Open Access
- 1 March 2020
- journal article
- research article
- Published by Taylor & Francis in ClinicoEconomics and Outcomes Research
- Vol. ume 12, 133-140
Abstract
Purpose: Non-communicable diseases impose a significant social, economic and health burden. Hypertension, the leading contributor to the global burden of disease and a growing public health problem worldwide, is one of the most serious non-communicable diseases. In Ethiopia, empirical evidence on the economic burden of hypertension is limited. Therefore, this study aimed to measure the cost of hypertension and associated factors at the University of Gondar comprehensive specialized hospital, northwest Ethiopia. Patients and Methods: An institution-based cross-sectional study was conducted on 442 adult hypertensive patients using a semi-structured questionnaire to estimate the direct and indirect costs of hypertension. The human capital approach was used to calculate indirect costs. A generalized linear model was fitted to identify factors associated with the cost of hypertension at a 95% confidence level and < 0.05 p-value. Results: A total of 442, 56.3% female and 64.3% stage one hypertension patients were included. The total cost of hypertension was ETB 2510.32 ($91.72) ± 2152.80 (78.65) per patient per year; The direct medical and non-medical cost constituted 60.81% and 12.17% of the total cost of hypertension, respectively. Hospitalized (exp(b)=1.87, p< 0.001), using multidrug (exp(b)=1.32, p< 0.000), high socioeconomic status (exp(b)=1.41,p< 0.000), college and above education(exp(b)= 1.35, p< 0.016), government employment (exp(b)= 1.30, p< 0.012), retirement (exp(b)= 0.71, p< 0.001) and co-morbidity (exp(b)= 1.20, p< 0.004) were factors significantly associated with the cost of hypertension. Conclusion: The total cost of illness of hypertension is high, and direct medical cost has the highest component of the total cost of illness. Hospitalization, using multidrug, co-morbidity, attending college and above education, highest socioeconomic status and government employment were factors significantly associated with the high cost of hypertension. Therefore, prevention and early detection of complications and co-morbidity are essential to reduce hospitalization and the number of drugs to reduce the direct medical and indirect costs.Keywords
This publication has 28 references indexed in Scilit:
- Prevalence of hypertension and its risk factors in southwest Ethiopia: a hospital-based cross-sectional surveyIntegrated Blood Pressure Control, 2013
- Inequalities in non-communicable diseases and effective responsesThe Lancet, 2013
- Prevalence and associated factors of hypertension among adults in Gondar, Northwest Ethiopia: a community based cross-sectional studyBMC Cardiovascular Disorders, 2012
- The economic burden of hypertension in rural south‐west ChinaTropical Medicine & International Health, 2012
- Regression models for analyzing costs and their determinants in health care: an introductory reviewInternational Journal for Quality in Health Care, 2011
- Cost-of-illness analysisHealth Policy, 2006
- The double burden of communicable and non-communicable diseases in developing countriesTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Socio-economic and geographic differentials in costs and payment strategies for primary healthcare services in Southeast NigeriaHealth Policy, 2004
- Clinical EconomicsJAMA, 1989
- Clinical economics. A guide to the economic analysis of clinical practicesJAMA, 1989